Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Current Assets (2018 - 2025)

Dna X (SONM) has disclosed Current Assets for 8 consecutive years, with $30.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 10.52% year-over-year to $30.3 million, compared with a TTM value of $30.3 million through Sep 2025, down 10.52%, and an annual FY2024 reading of $32.2 million, down 26.54% over the prior year.
  • Current Assets was $30.3 million for Q3 2025 at Dna X, up from $27.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $47.5 million in Q3 2023 and bottomed at $26.9 million in Q1 2025.
  • Average Current Assets over 5 years is $35.7 million, with a median of $33.9 million recorded in 2024.
  • The sharpest move saw Current Assets crashed 43.04% in 2021, then surged 39.42% in 2023.
  • Year by year, Current Assets stood at $35.7 million in 2021, then rose by 22.26% to $43.6 million in 2022, then rose by 0.36% to $43.8 million in 2023, then fell by 26.54% to $32.2 million in 2024, then decreased by 5.8% to $30.3 million in 2025.
  • Business Quant data shows Current Assets for SONM at $30.3 million in Q3 2025, $27.1 million in Q2 2025, and $26.9 million in Q1 2025.